HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Null genotype of GSTT1 contributes to colorectal cancer risk in Asian populations: evidence from a meta-analysis.

AbstractBACKGROUND/AIMS:
Studies of associations between genetic polymorphism of glutathione S-transferase T1(GSTT1) and risk of colorectal cancer (CRC) in Asian populations have reported controversial results. Thus, a meta-analysis was performed to clarify the effects of GSTT1 polymorphism on the risk of developing colorectal cancer.
METHODS:
A literature search of PubMed and EMBASE up to June 7, 2011 was conducted and 13 eligible papers were finally selected, involving totals of 4,832 CRC cases and 7,045 controls. Subgroup analyses were performed according to the sample size and the research design with the software programs Review Manager (version 5.0.10) and STATA (version 9.2).
RESULTS:
Analyses of all relevant studies showed an increased CRC risk was significantly associated with the null genotypes of GSTT1 (OR=1.09, 95%CI=1.01-1.17, POR=0.027; I2=40.2%). Besides, a more obvious association was observed after heterogeneity was eliminated (OR=1.13, 95%CI 1.04-1.23, POR=0.002; I2=0.0%). Subgroup analyses and sensitivity analysis further identified an association in Asians.
CONCLUSIONS:
This meta-analysis demonstrated the GSTT1 null genotype to be associated with an increased risk of CRC in Asian populations.
AuthorsDonghua Xu, Shushan Yan, Jie Yin, Pengjun Zhang
JournalAsian Pacific journal of cancer prevention : APJCP (Asian Pac J Cancer Prev) Vol. 12 Issue 9 Pg. 2279-84 ( 2011) ISSN: 2476-762X [Electronic] Thailand
PMID22296370 (Publication Type: Journal Article, Meta-Analysis)
Chemical References
  • glutathione S-transferase T1
  • Glutathione Transferase
Topics
  • Asian People
  • Case-Control Studies
  • Colorectal Neoplasms (enzymology, genetics)
  • Genetic Predisposition to Disease
  • Genotype
  • Glutathione Transferase (genetics)
  • Humans
  • Polymorphism, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: